These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8375782)

  • 1. Spectrophotometric detection of bacteriolytic activity of diluted lysostaphin solutions.
    Márová I; Kovár J
    Folia Microbiol (Praha); 1993; 38(2):153-8. PubMed ID: 8375782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of lysostaphin to remove cell-adherent staphylococci during in vitro assays of phagocyte function.
    Easmon CS; Lanyon H; Cole PJ
    Br J Exp Pathol; 1978 Aug; 59(4):381-5. PubMed ID: 708586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Chimeric LysK-Lysostaphin Fusion Enzyme Lysing Staphylococcus aureus Cells: a Study of Both Kinetics of Inactivation and Specifics of Interaction with Anionic Polymers.
    Filatova LY; Donovan DM; Ishnazarova NT; Foster-Frey JA; Becker SC; Pugachev VG; Balabushevich NG; Dmitrieva NF; Klyachko NL
    Appl Biochem Biotechnol; 2016 Oct; 180(3):544-557. PubMed ID: 27168405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-wall proteins of Staphylococcus aureus : a kinetic study of release by lysostaphin.
    Poutrel B; Dubray G
    Ann Rech Vet; 1978; 9(3):401-7. PubMed ID: 749643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of lysostaphin in in vitro assays of phagocyte function: adherence to and penetration into granulocytes.
    van den Broek PJ; Dehue FA; Leijh PC; van den Barselaar MT; van Furth R
    Scand J Immunol; 1981 May; 15(5):467-73. PubMed ID: 7345565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Staphylococcus aureus-lysing enzymes: isolation and some properties of lysostaphine].
    Surovtsev VI; Gusev VV; Borozdina MA; Paderin IuP; Khatiushin IuI; Chuprunov VP
    Vestn Ross Akad Med Nauk; 1999; (12):22-4. PubMed ID: 10709462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facile penetration of the Staphylococcus aureus capsule by lysostaphin.
    King BF; Biel ML; Wilkinson BJ
    Infect Immun; 1980 Sep; 29(3):892-6. PubMed ID: 7429637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of phagocytosis of 32P-labeled Staphylococcus aureus by bovine polymorphonuclear leukocytes.
    Dulin AM; Paape MJ; Weinland BT
    Am J Vet Res; 1984 Apr; 45(4):786-9. PubMed ID: 6731995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-specific N-glycosylation of caprine lysostaphin restricts its bacteriolytic activity toward Staphylococcus aureus.
    Huang CY; Hsu JT; Chung PH; Cheng WT; Jiang YN; Ju YT
    Anim Biotechnol; 2013; 24(2):129-47. PubMed ID: 23534959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell wall composition and decreased autolytic activity and lysostaphin susceptibility of glycopeptide-intermediate Staphylococcus aureus.
    Koehl JL; Muthaiyan A; Jayaswal RK; Ehlert K; Labischinski H; Wilkinson BJ
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3749-57. PubMed ID: 15388430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel S. aureus autolysins and molecular engineering to enhance bacteriolytic activity.
    Osipovitch DC; Therrien S; Griswold KE
    Appl Microbiol Biotechnol; 2015 Aug; 99(15):6315-26. PubMed ID: 25690309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and characterization of the antibacterial peptidase lysostaphin from Staphylococcus simulans: Adverse influence of Zn
    Chandra Ojha S; Imtong C; Meetum K; Sakdee S; Katzenmeier G; Angsuthanasombat C
    Protein Expr Purif; 2018 Nov; 151():106-112. PubMed ID: 29944958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Light and scanning-beam electron microscopy of wall-defective Staphylococcus aureus induced by lysostaphin.
    Watanakunakorn C; Fass RJ; Klainer AS; Hamburger M
    Infect Immun; 1971 Jul; 4(1):73-8. PubMed ID: 4949481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiseptic effect of compound lysostaphin disinfectant and its preventive effect on infection of artificial dermis after graft on full-thickness skin defect wound in rats].
    Jin J; Zhou H; Cui ZC; Wang L; Luo PF; Ji SZ; Hu XY; Ma B; Wang GY; Zhu SH; Xia ZF
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):225-232. PubMed ID: 29690741
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of four methods for determining lysostaphin susceptibility of various strains of Staphylococcus aureus.
    Kusuma CM; Kokai-Kun JF
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3256-63. PubMed ID: 16048934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence of lysostaphin to and penetration into human monocytes.
    van den Broek PJ; Buys LF; van Furth R
    Scand J Immunol; 1985 Feb; 21(2):189-93. PubMed ID: 3975574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LYSOSTAPHIN: A NEW BACTERIOLYTIC AGENT FOR THE STAPHYLOCOCCUS.
    SCHINDLER CA; SCHUHARDT VT
    Proc Natl Acad Sci U S A; 1964 Mar; 51(3):414-21. PubMed ID: 14171453
    [No Abstract]   [Full Text] [Related]  

  • 18. [Development of Streptococcus pyogenes cells inactivation for turbidimetric determination of bacteriolytic activity of phage-associated enzyme].
    Dmitrieva NF; Kliachko NL; Bondarenko VM; Shabanova NA; Eshchina AS; Filatova LIu; Morozova NI; Timofeev IuM; Kabanov AV; Briko NI
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (6):14-9. PubMed ID: 22308721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PURIFICATION AND PROPERTIES OF LYSOSTAPHIN--A LYTIC AGENT FOR STAPHYLOCOCCUS AUREUS.
    SCHINDLER CA; SCHUHARDT VT
    Biochim Biophys Acta; 1965 Feb; 97():242-50. PubMed ID: 14292833
    [No Abstract]   [Full Text] [Related]  

  • 20. Direct observation of Staphylococcus aureus cell wall digestion by lysostaphin.
    Francius G; Domenech O; Mingeot-Leclercq MP; Dufrêne YF
    J Bacteriol; 2008 Dec; 190(24):7904-9. PubMed ID: 18835985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.